Clinical Trial Update: Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of gemcitabine hydrochloride in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Mayo Clinic | Conditions: Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer | Phase 1 | Status: COMPLETED